1
项与 ADCC-R-Epo-R T-cells(National University Hospital, Singapore) 相关的临床试验Phase IB Followed by Phase II Study of Trastuzumab Combined With Autologous Chimeric Receptor T Cells in HER2+ Advanced Breast Cancer and Other Solid Tumors
This phase Ib study aims to assess the safety and feasibility of combination of chimeric receptor T cells with trastuzumab in patients with HER2+ solid tumors, with further expansion of study population in HER2+ metastatic breast cancer once safety has been established.
100 项与 ADCC-R-Epo-R T-cells(National University Hospital, Singapore) 相关的临床结果
100 项与 ADCC-R-Epo-R T-cells(National University Hospital, Singapore) 相关的转化医学
100 项与 ADCC-R-Epo-R T-cells(National University Hospital, Singapore) 相关的专利(医药)
100 项与 ADCC-R-Epo-R T-cells(National University Hospital, Singapore) 相关的药物交易